Aurobindo Pharma Ltd AUROPHARMA-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 08/03/21 IST
916.90UNCH (UNCH)
52 week range
738.05 - 1,063.90

...

Loading . . .
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close916.90
  • 52 Week High1,063.90
  • 52 Week High Date05/11/21
  • 52 Week Low738.05
  • 52 Week Low Date09/24/20

Key Stats

  • Market Cap7,223.61M
  • Shares Out585.94M
  • 10 Day Average Volume1.44M
  • Dividend4.88
  • Dividend Yield0.53%
  • Beta-
  • YTD % Change-1.28

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close916.90
  • 52 Week High1,063.90
  • 52 Week High Date05/11/21
  • 52 Week Low738.05
  • 52 Week Low Date09/24/20
  • Market Cap7,223.61M
  • Shares Out585.94M
  • 10 Day Average Volume1.44M
  • Dividend4.88
  • Dividend Yield0.53%
  • Beta-
  • YTD % Change-1.28

RATIOS/PROFITABILITY

  • EPS (TTM)91.03
  • P/E (TTM)10.07
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date02/22/2021
  • Div Amount1.50
  • Split Date-
  • Split Factor-

Latest On Aurobindo Pharma Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs). Its product portfolio is spread over seven therapeutic/product areas, including antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterologicals, anti-allergies and anti-diabetics. It is engaged in developing a range of oncology and hormonal products. It is also developing...
K. Nityananda Reddy
Vice Chairman
K Ragunathan
Non-Executive Chairman
Santhanam Subramanian
Chief Financial Officer
Address
Water Mark Building,, Plot No. 11
Survey no.9, Kondapur, Hitech City
Hyderabad,Telangana
Hyderabad
500081
India